Medical Image + Deep Learning Algorithm= Faster Cancer Diagnosis with Better Efficacy
Our mission – supporting cancer diagnosis by AI (machine and deep learning)
The number of deaths from cancers worldwide is staggering—8.8 million deaths in 2015 according to the World Health Organization! In the US alone 20% of all deaths are due to cancer each year. Our team at Cancer Center is driven and motivated to help fight these various forms of cancers around the world using advanced and innovative software tools for fast and effective early diagnosis and mitigation. We hope to contribute to the fight for eradicating and preventing cancers by collaborating with medical professionals and researchers worldwide.
Using Deep Learning (DL) and Machine Learning (ML) platforms, we have developed specialized algorithmic solutions to analyze medical images for oncology and radiology for faster and better than human accuracy. Our solutions, which are both in API and Web Platforms, are designed to offer faster and better access for second and third diagnostic opinions by medical professionals to help develop a therapeutic approach quickly. This will help the patients and physicians by reducing anxiety caused by not knowing what they are dealing with.
Our solutions do all the work—segment images, find regions of interests, generate statistical descriptions of images, count cells, mitosis, and even recognize the type of cell.
Your focus—saving lives, our focus—image processing and fast detection!
- Machine Learning / Deep Learning
- Automated Medical Image Analysis
- MRI (Magnetic Resonance Imaging)
- PET / CT
- Pathology Images (Whole Slide Imaging)
- General planimetry
MRI, DICOM Analysis
It is one of the most important and most profitable diagnostic tools. Not only this medical imaging modality is not invasive but also can be applied in many different scenarios, obtaining images of pretty much every part of the human body. In case of the prostate cancer, our software/deep learning algorithms can be used to find Region of Interest (ROI), cancer segmentation automatically.
In terms of precision, there are no better methods of seeing a single tissue as… to examine the tissue under the microscope. Every histopathologist would agree that sometimes finding the most descriptive part of the slide is a harder task than it is to make the diagnosis itself. Fortunately, it is not a problem for us. We can localize the most important parts of the slide, what is more, we can extract the very factors that influence diagnostic models the most. We offer Manual Whole Slide Imaging Software (PathoCam) to save pathology images by using your own microscope equipment and PathoViewer to zoom/view, annotate and share it by web/browser.
In oncology, Positron Emission Tomography (PET) imaging is widely used in diagnostics of cancer metastases, in monitoring of progress in course of the cancer treatment, and in planning radiotherapeutic interventions. Accurate and reproducible delineation of the tumor in the PET scans remains a difficult task, despite being crucial for delivering appropriate radiation dose, minimizing adverse side-effects of the therapy, and reliable evaluation of treatment. Our aim is to provide clinicians with intelligent software supporting accurate, efficient and reproducible delineation of the tumor.
Latest News & Blog
We take part in MEDICA - the leading international trade fair for the medical sector in Düsseldorf / Germany from 12 - 15 November 2018. We present our new product for Pathologists and researchers: micro.cancercenter.ai [gallery link="file"...
This year’s TC Disrupt attracted some of the world’s top tech startups with the biggest influencers from Silicon Valley and other parts of the world! Featured guests included Uber CEO Dara Knosrowshahi, Greylock Partners’ Reid Hoffman, Bumble Founder & CEO Whitney...
We've been on Pioneers in Vienna on 24-25 April 2018.
We've just got the email from nVidia: "Congratulations! You’re in Inception. After careful review, we have determined Cancer Center is a great fit for NVIDIA’s Inception Program. Thank you for advancing the field of Artificial Intelligence (AI) in a meaningful way!"...
FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems
Good news! The U.S. Food and Drug Administration today permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes. Diabetic retinopathy occurs...